or
forgot password
  • cancer clinical trials in indianapolis, IN

  • Study of Oral LBH589 in Adult Patients With Refractory Cutaneous T-Cell Lymphoma
    Indiana University Dept. of IU Cancer Center
    Indianapolis, Indiana 46202
    Cutaneous T-Cell Lymphoma
    Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
    Indiana University Medical Center

    Trial Locations
    Indiana University Medical Center
    Wishard Hospital
    Saint Vincent Hospital and Health Services
    Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    Levonorgestrel in Preventing Ovarian Cancer in Patients at High Risk for Ovarian Cancer
    Indiana University Melvin and Bren Simon Cancer Center
    Indianapolis, Indiana 46202-5289
    Ovarian Cancer
    Donor Bone Marrow Transplant With or Without G-CSF in Treating Young Patients With Hematologic Cancer or Other Diseases
    Indiana University Medical Center

    Trial Locations
    Indiana University Medical Center
    Riley Hospital for Children
    Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Childhood Chronic Myelogenous Leukemia, Childhood Myelodysplastic Syndromes, Chronic Phase Chronic Myelogenous Leukemia, de Novo Myelodysplastic Syndromes, Juvenile Myelomonocytic Leukemia, Previously Treated Myelodysplastic Syndromes, Recurrent Childhood Acute Lymphoblastic Leukemia, Secondary Myelodysplastic Syndromes
    A Study of Intravenous XMT-1001 in Patients With Advanced Solid Tumors
    Central Indiana Cancer Centers
    Indianapolis, Indiana 46227
    Small Cell Lung Cancer, Non-small Cell Lung Cancer
    Safety Study of CAT-8015 Immunotoxin in Patients With CLL, PLL or SLL With Advance Disease
    Indiana University Cancer Center
    Indianapolis, Indiana 46202-5265
    Leukemia
    Assessing Ear Damage in Young Cancer Patients Treated With Cisplatin
    Riley's Children Cancer Center at Riley Hospital for Children
    Indianapolis, Indiana 46202-5225
    Ototoxicity, Unspecified Childhood Solid Tumor, Protocol Specific
    VEGF Trap in Treating Patients With Recurrent or Persistent Endometrial Cancer
    Saint Vincent Hospital and Health Services
    Indianapolis, Indiana 46260
    Recurrent Endometrial Carcinoma
    Trial of Dasatinib in Advanced Sarcomas
    Indiana University Cancer Center
    Indianapolis, Indiana 46202-5265
    Rhabdomyosarcoma, Malignant Peripheral Nerve Sheath Tumors, Chondrosarcoma, Sarcoma, Ewing's, Sarcoma, Alveolar Soft Part, Chordoma, Epithelioid Sarcoma, Giant Cell Tumor of Bone, Hemangiopericytoma, Gastrointestinal Stromal Tumor (GIST)
    Combination Chemotherapy in Treating Young Patients With Recurrent or Resistant Malignant Germ Cell Tumors
    Indiana University Melvin and Bren Simon Cancer Center
    Indianapolis, Indiana 46202-5289
    Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor, Ovarian Cancer, Testicular Germ Cell Tumor
    Prostate Cancer Study In Men Who Have Failed First-Line Androgen Deprivation Therapy
    GSK Investigational Site
    Indianapolis, Indiana 46260
    Neoplasms, Prostate, Prostate Cancer
    Lapatinib in Combination With Radiation Therapy in Patients With Brain Metastases From HER2-Positive Breast Cancer
    Indiana University Melvin and Bren Simon Cancer Center
    Indianapolis, Indiana 46202-5289
    Breast Cancer, Brain Metastases
    A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
    Dawes Fretzin Clinical Research Group, LLC

    Trial Locations
    Dawes Fretzin Clinical Research Group, LLC
    Dermatology Associates, PC
    Atopic Dermatitis
    GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer
    GSK Investigational Site
    Indianapolis, Indiana 46260
    Lung Cancer, Non-Small Cell
    ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D
    GSK Investigational Site
    Indianapolis, Indiana 46260
    Neoplasms, Breast, Breast Cancer
    Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer
    Indiana University Medical Center
    Indianapolis, Indiana 46202
    Endometrial Cancer
    Adj TC + Herceptin Early Stage Breast Cancer
    Central Indiana Cancer Centers
    Indianapolis, Indiana 46227
    Breast Cancer
    TAC Versus TC for Adjuvant Breast Cancer
    Central Indiana Cancer Centers
    Indianapolis, Indiana 46227
    Breast Cancer
    Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer
    Indiana University Melvin and Bren Simon Cancer Center

    Trial Locations
    Indiana University Melvin and Bren Simon Cancer Center
    William N. Wishard Memorial Hospital
    Veterans Affairs Medical Center - Indianapolis
    Lung Cancer
    Randomized Phase 3b Study in Previously Untreated Multiple Myeloma Patients: VELCADE,Thalidomide, and Dexamethasone Versus VELCADE and Dexamethasone Versus VELCADE, Melphalan, and Prednisone
    Central Indiana Cancer Centers

    Trial Locations
    Central Indiana Cancer Centers
    Investigative Clinical Research of Indiana, LLC
    Multiple Myeloma
    First-Line Chemotherapy and Trastuzumab With or Without Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEU
    Indiana University Medical Center

    Trial Locations
    Indiana University Medical Center
    Wishard Hospital
    Saint Vincent Hospital and Health Services
    HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer
    Phase I/Randomized Phase II Study of Second Line Therapy With Irinotecan + Cetuximab +/- RAD001 for Colorectal Cancer
    IN Onc/Hem Associates

    Trial Locations
    IN Onc/Hem Associates
    St. Vincent Hospital & Health Centers
    Colorectal Cancer
    High-Dose or Standard-Dose Radiation Therapy and Chemotherapy With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
    Community Regional Cancer Care at Community Hospital North

    Trial Locations
    Community Regional Cancer Care at Community Hospital North
    Community Regional Cancer Care at Community Hospital East
    Central Indiana Cancer Centers - East
    Lung Cancer, Radiation Toxicity
    Selumetinib in Treating Woman With Recurrent Low-Grade Ovarian Cancer or Peritoneum Cancer
    Saint Vincent Hospital and Health Services
    Indianapolis, Indiana 46260
    Borderline Ovarian Surface Epithelial-stromal Tumor, Ovarian Serous Cystadenocarcinoma, Primary Peritoneal Cavity Cancer, Recurrent Borderline Ovarian Surface Epithelial-stromal Tumor
    Combination Chemotherapy With or Without Lestaurtinib in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia
    St. Vincent Indianapolis Hospital

    Trial Locations
    St. Vincent Indianapolis Hospital
    Riley's Children Cancer Center at Riley Hospital for Children
    Leukemia
    Memantine in Preventing Side Effects in Patients Undergoing Whole-Brain Radiation Therapy for Brain Metastases From Solid Tumors
    Methodist Cancer Center at Methodist Hospital

    Trial Locations
    Methodist Cancer Center at Methodist Hospital
    Indiana University Melvin and Bren Simon Cancer Center
    Community Regional Cancer Care at Community Hospital North
    Community Regional Cancer Care at Community Hospital East
    Central Indiana Cancer Centers - East
    Cognitive/Functional Effects, Metastatic Cancer, Neurotoxicity, Unspecified Adult Solid Tumor, Protocol Specific
    A Phase I Trial of Alloreactive Cell Infusion Following Transplantation of Haplotype Cells in Patients With Myeloid Malignancies
    Indiana University Cancer Center
    Indianapolis, Indiana 46202-5265
    Leukemia, Myeloid, Acute, Leukemia, Lymphoid, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic
    Vaccine Study for Surgically Resected Pancreatic Cancer
    Indiana University
    Indianapolis, Indiana 46202
    Pancreatic Cancer
    Sorafenib and Bevacizumab in Combination With Paclitaxel in Patients With Solid Tumors
    Indiana University Cancer Center
    Indianapolis, Indiana 46202-5265
    SOLID TUMORS
    Efficacy and Safety of OncoGelâ„¢ Added to Chemotherapy and Radiation Before Surgery in Subjects With Esophageal Cancer
    Indiana University Medical Center
    Indianapolis, Indiana 46202
    Esophageal Cancer, Adenocarcinoma of the Esophagus, Squamous Cell Carcinoma
    AMG 706 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    St. Vincent Indianapolis Hospital
    Indianapolis, Indiana 46260
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Medroxyprogesterone +/- Cyclophosphamide & Methotrexate in Hormone Receptor-Negative Recurrent/Metastatic Breast Cancer
    Indiana University Melvin and Bren Simon Cancer Center
    Indianapolis, Indiana 46202-5289
    Estrogen Receptor-negative Breast Cancer, Progesterone Receptor-negative Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer
    Prevalence of Lymphoma in IBD
    Indiana University Medical Center
    Indianapolis, Indiana 46202
    Lymphoma, Inflammatory Bowel Disease
    Clinical Impact of EUS in Staging NSCLC
    Indiana University Medical Center; Clarian Health
    Indianapolis, Indiana 46202
    Non Small Cell Lung
    Lung Cancer Location: a Repository
    Clarian/IUPUI: University Hospital
    Indianapolis, Indiana 46202
    Lung Cancer